Two Ohio Men File Joint Actos Bladder Cancer Lawsuit

The Actos lawsuit was filed by David Shaw and Frank Johnson, along with their wives Mary Shaw and Margaret Johnson, on September 20, 2013. Mr. Shaw began taking Actos to treat his type-2 diabetes in 2008 and was diagnosed with bladder cancer in December 2009. Mr. Johnson began taking Actos in April 2006, and was diagnosed with bladder cancer on March 24, 2009, according to the lawsuit.

Both men allege in the Actos lawsuit that they suffered serious physical pain and have faced steep hospital bills as a result of their bladder cancer treatments. They are also claiming to have permanent injuries from their bladder cancer and say they will have to undergo more medical treatments in the future.

There are 3,000 Actos lawsuits that have been filed against Takeda across the country claiming that Takeda did not give proper warning to doctors about the side effects of Actos, including that it increases the risk of patients developing bladder cancer.

The U.S. Food & Drug Administration announced in June 2011 that the Actos warning label would be updated to reflect that using Actos for more than one year increases the risk of bladder cancer.

Several studies have been released in recent years showing the connection between Actos and bladder cancer. Kaiser Permanente released a 10-year study that revealed that the risk of developing bladder cancer from Actos increases significantly the more a person ingests of the drug and the longer one is on the medication, especially after two years.

The British Medical Journal (BMJ) released a study showing that Actos users who took the medication for more than two years doubled their chances of developing bladder cancer. Another study released by the Canadian Medical Association Journal released a study that showed that using Actos increased the chances of developing bladder cancer by 22%.

Bloomberg News reported in 2011 that the FDA also found a link between Actos and heart problems. Takeda pulled Actos from the French and German markets in June 2011 due to the concerns of the officials there.

The Actos cancer lawsuit claims that Takeda knew about the dangerous bladder cancer side effects associated with the type-2 diabetes medication, but did not disclose those risks to either the doctors or patients who were taking the drug.

The plaintiffs are charging Takeda include strict liability, negligence, manufacturing defect, defective design, inadequate warning, breach of express and implied warranty, and violation of consumer protection laws. They are also seeking loss of consortium for their wives, who claim that the relationships with their husbands suffered as a result of the bladder cancer.

The two Ohio residents are asking to be compensated for the medical costs they incurred as a result of the Actos bladder cancer, punitive damages, attorney fees and costs, and any other compensation that the court decides is appropriate.

The Actos bladder cancer lawsuit is David Shaw, et al. v. Takeda Pharmaceuticals U.S.A. Inc., et al., Case No. 13-cv-02710-RFD-PJH. It was filed into multidistrict litigation consolidating hundreds of Actos bladder cancer lawsuits, known as In Re: Actos (Pioglitazone) Products Liability Litigation, MDL No. 2299, U.S. District Court, Western Division of Louisiana.

If you or someone you know has developed bladder cancer and used Actos as a diabetes treatment, legal options are available. Learn more and get a free legal review of your case at the Actos Bladder Cancer Class Action Lawsuit Investigation. Experienced legal professionals have access to medical experts to assess whether or not this diabetes drug played a role in your bladder cancer or other serious side effects, so act now.